Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin
- PMID: 2849758
- PMCID: PMC339002
- DOI: 10.1093/nar/16.23.11157
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin
Abstract
Camptothecin is an antitumor drug, which is a specific inhibitor of eukaryotic topoisomerase I. Enzyme inhibition is related to the stabilization of cleavable complexes between topoisomerase I and DNA. The genomic and DNA sequence localization of L1210 topoisomerase I-mediated DNA breaks produced by camptothecin were determined in the SV40 genome. DNA cleavage was predominantly single-stranded and localized in selective regions of the DNA. A major cleavage site was found at nucleotide 4995 on the coding strand in the early transcription region. The DNA sequence was determined at prominent cleavage sites (nucleotides 127 and 199 in the two 72 bp repeats and nucleotide 4955). A DNA consensus sequence 5'-GATG-3' was found in SV40 DNA. Cleavage occurred between the T and the G and topoisomerase I was linked to the 3'-DNA terminus at the T position. The sequence GATG is more frequent in the non transcribed strand of the early and late transcription of SV40 than in the transcribed strands. This finding is consistent with the role of topoisomerase I in transcription.
Similar articles
-
Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.Cancer Res. 1988 Apr 1;48(7):1722-6. Cancer Res. 1988. PMID: 2832051
-
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.J Biol Chem. 1991 Oct 25;266(30):20418-23. J Biol Chem. 1991. PMID: 1657924
-
Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.Cancer Res. 1989 Sep 15;49(18):5077-82. Cancer Res. 1989. PMID: 2548710
-
Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins.Semin Oncol. 1996 Feb;23(1 Suppl 3):3-10. Semin Oncol. 1996. PMID: 8633251 Review.
-
Camptothecin resistance related to drug-induced down-regulation of topoisomerase I and to steps occurring after the formation of protein-linked DNA breaks.Ann N Y Acad Sci. 1996 Dec 13;803:74-92. doi: 10.1111/j.1749-6632.1996.tb26378.x. Ann N Y Acad Sci. 1996. PMID: 8993502 Review. No abstract available.
Cited by
-
DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.Cancer Chemother Pharmacol. 1993;32(2):103-8. doi: 10.1007/BF00685611. Cancer Chemother Pharmacol. 1993. PMID: 8387398 Review. No abstract available.
-
Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.Nucleic Acids Res. 1990 Mar 25;18(6):1499-508. doi: 10.1093/nar/18.6.1499. Nucleic Acids Res. 1990. PMID: 2158079 Free PMC article.
-
DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin.Protein Sci. 2009 Jun;18(6):1326-31. doi: 10.1002/pro.138. Protein Sci. 2009. PMID: 19472416 Free PMC article.
-
Sequence dependent modulating effect of camptothecin on the DNA-cleaving activity of the calf thymus type I topoisomerase.Nucleic Acids Res. 1990 Feb 11;18(3):637-45. doi: 10.1093/nar/18.3.637. Nucleic Acids Res. 1990. PMID: 2155407 Free PMC article.
-
Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.Mol Cancer Ther. 2015 Nov;14(11):2552-9. doi: 10.1158/1535-7163.MCT-15-0454. Epub 2015 Sep 8. Mol Cancer Ther. 2015. PMID: 26351326 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources